DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY 2025 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.800-2.000 for the period, compared to the consensus estimate of 1.910. The company issued revenue guidance of $3.5 billion-$3.6 billion, compared to the consensus revenue estimate of $3.7 billion.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY traded down $0.84 during mid-day trading on Friday, reaching $16.32. The company had a trading volume of 1,831,716 shares, compared to its average volume of 2,442,860. The company has a 50-day moving average price of $18.88 and a two-hundred day moving average price of $21.55. The stock has a market cap of $3.24 billion, a PE ratio of -7.89, a P/E/G ratio of 1.80 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 1-year low of $16.35 and a 1-year high of $34.91.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.92%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Analyst Ratings Changes

A number of research firms have recently issued reports on XRAY. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a report on Friday. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a report on Friday. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday. Finally, StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.